Effect of long-term antibiotic use on weight in adolescents with acne

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 4, 2016, Pages 1098-1105

  Contopoulos Ioannidis, Despina G ^a,b   Ley, Catherine ^a   Wang, Wei ^b   Ma, Ting ^a   Olson, Clifford ^b   Shi, Xiaoli ^b   Luft, Harold S ^b   Hastie, Trevor ^a   Parsonnet, Julie ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ACNE; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; WEIGHT GAIN; ACNE VULGARIS; ADULT; CHILD; DRUG EFFECTS; FEMALE; MALE; STATISTICAL MODEL; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BODY WEIGHT; CHILD; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84964342482     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv455     Document Type: Article

References (56)

1. Ogden CL, Carroll MD, Kit BK et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311: 806-14.
2. Ley RE, Backhed F, Turnbaugh P et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-5.
3. Ley RE, Turnbaugh PJ, Klein S et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-3.
4. Turnbaugh PJ, Ley RE, Mahowald MA et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-31.
5. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-4.
6. Gill SR, Pop M, Deboy RTet al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-9.
7. Vijay-Kumar M, Aitken JD, Carvalho FA et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-31.
8. Raoult D. Obesity pandemics and the modification of digestive bacterial flora. Eur J Clin Microbiol Infect Dis 2008; 27: 631-4.
9. Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 2010; 69: 434-41.
10. Acar J, Casewell M, Freeman J et al. Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin Microbiol Infect 2000; 6: 477-82.
11. Collignon P, Wegener HC, Braam P et al. The routine use of antibiotics to promote animal growth does little to benefit protein undernutrition in the developing world. Clin Infect Dis 2005; 41: 1007-13.
12. Gorbach SL. Antimicrobial use in animal feed-time to stop. N Engl J Med 2001; 345: 1202-3.
13. Diarra MS, Malouin F. Antibiotics in Canadian poultry productions and anticipated alternatives. Front Microbiol 2014; 5: 282.
14. Castanon JI. History of the use of antibiotic as growth promoters in European poultry feeds. Poult Sci 2007; 86: 2466-71.
15. Khan M, Raoult D, Richet H et al. Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br Poult Sci 2007; 48: 732-5.
16. Patterson JA, Burkholder KM. Application of prebiotics and probiotics in poultry production. Poult Sci 2003; 82: 627-31.
17. Haight TH, Pierce WE. Effect of prolonged antibiotic administration of the weight of healthy young males. J Nutr 1955; 56: 151-61.
18. Rosenberg IH, Beisel WR, Gordon JE et al. Infant and child enteritismalabsorption-malnutrition: the potential of limited studies with lowdose antibiotic feeding. Am J Clin Nutr 1974; 27: 304-9.
19. Ajslev TA, Andersen CS, Gamborg M et al. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, prepregnancy weight and early administration of antibiotics. Int J Obes (Lond) 2011; 35: 522-9.
20. Trasande L, Blustein J, LiuMet al. Infant antibiotic exposures and earlylife body mass. Int J Obes (Lond) 2013; 37: 16-23.
21. Murphy R, Stewart AW, Braithwaite I et al. Antibiotic treatment during infancy and increased body mass index in boys: an international crosssectional study. Int J Obes (Lond) 2014; 38: 1115-9.
22. Mueller NT, Whyatt R, Hoepner L et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond) 2015; 39: 665-70.
23. Al-Hosni M, Duenas M, Hawk M et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 2012; 32: 253-9.
24. Sazawal S, Dhingra U, Hiremath G et al. Effects of Bifidobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia, and growth among children 1 to 4 years old. J Pediatr Gastroenterol Nutr 2010; 51: 341-6.
25. Vendt N, Grünberg H, Tuure T et al. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J Hum Nutr Diet 2006; 19: 51-8.
26. Mohan R, Koebnick C, Schildt J et al. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res 2008; 64: 418-22.
27. Kanamori Y, Sugiyama M, Hashizume K et al. Experience of longterm synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 2004; 39: 1686-92.
28. Uchida K, Takahashi T, Inoue M et al. Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int 2007; 23: 243-8.
29. Underwood MA, Salzman NH, Bennett SH et al. A randomized placebocontrolled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr 2009; 48: 216-25.
30. Chou IC, Kuo HT, Chang JS et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatr 2010; 156: 393-6.
31. Gough EK, Moodie EE, Prendergast AJ et al. The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials. BMJ 2014; 348: g2267.
32. Wong EC, Palaniappan LP, Lauderdale DS. Using name lists to infer Asian racial/ethnic subgroups in the healthcare setting. Med Care 2010; 48: 540-6.
33. CDC. A SAS Program for the CDC Growth Charts. http://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas.htm.
34. von ElmE, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-7.
35. Kosanke J, Bergstralh E. gmatch SAS Macro. October 2003. http://www.mayo.edu/research/documents/gmatchsas/doc-10027248.
36. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2013.
37. Lees CD, O'Neill M, Steiger E. The effect of intravenous doxycycline hyclate on total parenteral nutrition in protein malnourished rats. JPEN J Parenter Enteral Nutr 1981; 5: 510-2.
38. Graham JP, Boland JJ, Silbergeld E. Growth promoting antibiotics in food animal production: an economic analysis. Public Health Rep 2007; 122: 79-87.
39. Bäckhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-123.
40. Turnbaugh PJ, Ridaura VK, Faith JJ et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1: 6ra14.
41. Dumas ME, Barton RH, Toye A et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006; 103: 12511-6.
42. Armougom F, Henry M, Vialettes B et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009; 4: e7125.
43. Duncan SH, Lobley GE, Holtrop G et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008; 32: 1720-4.
44. Santacruz A, Marcos A, Wärnberg J et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009; 17: 1906-15.
45. Nadal I, Santacruz A, Marcos A et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes (Lond) 2009; 33: 758-67.
46. ZhangH, DiBaise JK, ZuccoloAet al. Human gutmicrobiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009; 106: 2365-70.
47. Trehan I, Goldbach HS, LaGrone LN et al. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med 2013; 368: 425-35.
48. Smith MI, Yatsunenko T, Manary MJ et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339: 548-54.
49. DiBaise JK, Zhang H, Crowell MD et al. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008; 83: 460-9.
50. Angelakis E, Merhej V, Raoult D. Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 2013; 13: 889-99.
51. Azad MB, Bridgman SL, Becker AB et al. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond) 2014; 38: 1290-8.
52. Bailey LC, Forrest CB, Zhang P et al. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 2014; 168: 1063-9.
53. Cox LM, Yamanishi S, Sohn J et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014; 158: 705-21.
54. Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol 2015; 11: 182-90.
55. Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-7.
56. Angelakis E, Million M, Kankoe S et al. Abnormal weight gain and gut microbiota modifications are side effects of long-term doxycycline and hydroxychloroquine treatment. Antimicrob Agents Chemother 2014; 58: 3342-7.